The stock listed at Rs 90, a 53 per cent premium to its issue price of Rs 59 per share on the National Stock Exchange (NSE) on Monday.
The fall in the Indian market is far subdued, compared to many global peers that have slipped into bear-market territory
Anand Rathi Wealth reported strong growth in asset under management (AUM) of 16 per cent YoY at Rs 35,842 crore.
The company raised its full-year revenue growth guidance to 13.5-14.5 per cent, from 12-14 per cent on a constant currency (CC) basis, citing strong order bookings and pipeline.
The pharma company said it will respond to the European medical regulator with appropriate corrective and preventive actions within the stipulated time.
Following the development, global brokerage JP Morgan downgraded the stock from 'overweight' to 'neutral' with a September 2023 price target of Rs 455.
The Nifty Metal index can rally up to 11 per cent following the breakout. Among individual stocks, Tata Steel needs to conquer its 200-DMA to gain strength.
The company's electronics vertical is expected to emerge as the key business and profitability driver over the coming years.
As per the revised terms, the said transaction price was reduced from euro 600 million to euro 520 million.
The 200-DMA is generally a good indicator of a long-term trend
US markets surge after worst September in two decades
More than the monetary policy decision, the RBI's assessment of inflation and growth propelled the markets, said experts
Kotak Mahindra Bank, HDFC Bank, Axis Bank, State Bank of India, HDFC, ICICI Bank, SBI Life Insurance and SBI Cards from the Nifty Financial index gained up to 2 per cent each.
Firms raised a total of Rs 36,535 cr in the period, 30.2% less than Rs 52,325 cr last yr
Sun Pharma could see structural growth and be relatively insulated from the adverse price erosion scenario in the US, according to analysts.
The fresh sell-off on Monday pulled another 37 stocks below 200-DMA taking the total tally to 268
Until the S&P BSE Sensex and Nifty50 do not break 57,000 and 17,000 levels, there are higher changes of touching 64,000 and 19,000 levels.
Financials and pharma stocks led the advance amid positive flows from foreign portfolio investors
The order is for supply and installation of modular interiors for Vande Bharat semi-high speed trains (originally called Train 18)
Market is building an earnings growth of 10-12 per cent for FY23, which seems achievable given the present earnings momentum and economic outlook, says Sanjay Chawla of Baroda BNP Paribas MF.